The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Wed, 02nd Oct 2019 10:23

(Alliance News) - Cello Health PLC said Wednesday it has sold its social media analytics software business Pulsar to Access Intelligence PLC for GBP4.5 million in shares.

Access Intelligence will issue to Cello 8.7 million Access Intelligence shares and a payment of GBP1. The two companies said the all-share deal recognises the "ongoing value" of Pulsar to Cello's clients.

Access Intelligence also announced it has raised GBP3.3 million through the placing of 6.3 million new shares at a price of 52.0 pence each, the same as the implied price of the issuance to Cello.

Shares in Cello Health were 2.4% higher in London on Wednesday morning at 130.0p each. Access Intelligence was 4.6% lower at 52.00p.

"Access Intelligence and Cello to continue to work in partnership where there are mutual client opportunities for Pulsar's expertise," the companies added.

Pulsar holds Fenix Media Ltd and Face US Inc. Pulsar Chief Executive Francesco D'Orazio will be issued 229,327 Access Intelligence shares as part of the deal.

Cello Health said the sale will allow it to focus on its "higher growth and higher margin" healthcare business, as well as further supporting its core Signal unit.

Cello Chief Executive Mark Scott said: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."

Access Intelligence said the deal is in line with its growth strategy.

Access Intelligence CEO Joanna Arnold added: "I am delighted with the acquisition of Pulsar which demonstrates our commitment to work with the best people and technology to accelerate the products and services we can offer. The Vuelio and ResponseSource products provide market leading monitoring, insight, engagement and evaluation tools that will be improved by the addition of Pulsar, which will deliver significantly improved social media capability."

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
7 Aug 2020 20:11

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

Read more
4 Aug 2020 09:05

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Read more
1 Jul 2020 12:10

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the company at £179m.

Read more
13 May 2020 16:18

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Apr 2020 12:53

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

Read more
7 Apr 2020 12:47

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

Read more
6 Apr 2020 15:17

Access Intelligence Records Widened Annual Loss As Expenses Rise

Access Intelligence Records Widened Annual Loss As Expenses Rise

Read more
18 Mar 2020 14:25

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Read more
11 Mar 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Feb 2020 13:32

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Read more
6 Feb 2020 11:21

Cello Health settles with Access Intelligence over Pulsar sale

(Sharecast News) - Healthcare-focussed advisory group Cello Health updated the market on post-completion adjustments in its sale of the Pulsar platform to Access Intelligence on Thursday.

Read more
16 Jan 2020 12:58

Cello Health Reports "Excellent Year" As Restructures Signal Division

Cello Health Reports "Excellent Year" As Restructures Signal Division

Read more
7 Oct 2019 15:23

Cello Health Secures 11% Holding In Access Intelligence

Cello Health Secures 11% Holding In Access Intelligence

Read more
2 Oct 2019 14:15

Cello Health sells Pulsar business to Access Intelligence

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.